[1] Muneera K, Majeed A.Naveed AK.Comparative evaluation of Nigella sativa (Kalonji) and simvastatin for the treatment of hyperlipidemia and in the induction of hepatotoxicity[J].Pak J Pharm Sci, 2015, 28(2):493-498.
[2] van Rooij E, Olson EN.MicroRNAs: Powerful new regulators of heart disease and provocative therapeutic targets[J].J Clin Invest, 2007, 117(9):2369-2376.
[3] Xu WD, Lu MM, Pan HF, et al.Association of MicroRNA-146a with autoimmune diseases[J].Inflammation, 2012, 35(4):1525-1529.
[4] Huffaker TB, Hu R, Runtsch MC, et al.Epistasis between microRNAs 155 and 146a during T cell-mediated antitumor immunity[J].Cell Rep, 2012, 2(6):1697-1709.
[5] Gao M, Wang X, Zhang X, et al.Attenuation of cardiac dysfunction in polymicrobial sepsis by microrna-146a is mediated via targeting of IRAK1 and TRAF6 expression[J].J Immunol, 2015, 195 (2):672-682.
[6] Seo HH, Lee SY, Lee CY, et al.Exogenous miRNA-146a enhances the therapeutic efficacy of human mesenchymal stem cells by increasing vascular endothelial growth factor secretion in the ischemia/reperfusion-injured heart[J].J Vasc Res, 2017, 54 (2):100-108.
[7] Kim YR, Hong SH.Associations of MicroRNA polymorphisms (miR-146a, miR-196a2, and miR-499) with the risk of hypertension in the Korean population[J].Genet Test Mol Bioma, 2016, 20(8):420-426.
[8] Yang ZX, Wang YZ, Jia BB, et al.Downregulation of miR-146a, cyclooxygenase-2 and advanced glycation end-products in simvastatin-treated older patients with hyperlipidemia[J].Geriatr Gerontol Int, 2016, 16(3):322-328.
[9] Feng B, Chen S, Gordon AD, et al.miR-146a mediates inflammatory changes and fibrosis in the heart in diabetes[J].J Mol Cell Cardiol, 2017, 105(4):70-76.
[10] Latronico MV, Catalucci D, Condorelli G.MicroRNA and cardiac pathologies[J].Physiol Genomics, 2008, 34 (3):239-242.
[11] Emadi SS, Soufi FG, Khamaneh AM, et al.MicroRNA-146a expression and its intervention in NF-кB signaling pathway in diabetic rat aorta[J].Endocr Regul, 2014, 48 (2):103-108.
[12] Eftekhar E, Doustaki Zaboli M, Katebi M, et al.MicroRNA-146a and its adapter proteins are affected by diabetes in rat’s heart[J].Bratisl Lek Listy, 2016, 117(3):166-170.
[13] Miki T, Yuda S, Kouzu H, et al.Diabetic cardiomyopathy: pathophysiology and clinical features[J].Heart Fail Rev, 2013, 18 (2):149-166.
[14] Westerink J, van der Graaf Y, Faber DR, et al.Relation between thyroid-stimulating hormone and the occurrence of cardiovascular events and mortality in patients with manifest vascular diseases[J].Eur J Prev Cardiol, 2012, 19(4):864-873.
[15] Danzi S, Klein I.Thyroid disease and the cardiovascular system[J].Endocrinol Metab Clin North Am, 2014, 43(2):517-528.
[16] Tian L, Ni J, Guo T, et al.TSH stimulates the proliferation of vascular smooth muscle cells[J].Endocrine, 2014, 46(3):651-658.
[17] Alibaz Oner F, Yurdakul S, Oner E, et al.Evaluation of the effect of L-thyroxin therapy on endothelial functions in patients with subclinical hypothyroidism[J].Endocrine, 2011, 40(2):280-284.
[18] Cheng HS, Sivachandran N, Lau A, et al.MicroRNA-146 represses endothelial activation by inhibiting pro-inflammatory pathways[J].EMBO Mol Med, 2013, 5(7):1017-1034.
[19] Dong S, Xiong W, Yuan J, et al.MiRNA-146a regulates the maturation and differentiation of vascular smooth muscle cells by targeting NF-κB expression[J].Mol Med Rep, 2013, 8(2):407-412.
[20] Li K, Ching D, Luk FS, et al.Apolipoprotein enhances microrna-146a in monocytes and macrophages to suppress nuclear factor-kappab-driven inflammation and atherosclerosis[J].Circ Res, 2015, 117(1):e1-e11.
[21] Vasa-Nicotera M, Chen H, Tucci P, et al.MiR-146a is modulated in human endothelial cell with aging[J].Atherosclerosis, 2011, 217(2):326-330.
[22] Wu ZW, Liu YF, Wang S, et al.miRNA-146a induces vascular smooth muscle cell apoptosis in a rat model of coronary heart disease via NF-κB pathway[J].Genet Mol Res, 2015, 14(4):18703-18712.
[23] Li J, Huang J, Dai L, et al.miR-146a, an IL-1β miRNA, induces vascular endothelial growth factor and chondrocyte apoptosis by targeting Smad4[J].Arthritis Res Ter, 2012, 14(2):1.
[24] Zhu K, Pan Q, Zhang X, et al.MiR-146a enhances angiogenic activity of endothelial cells in hepatocellular carcinoma by promoting PDGFRA expression[J].Carcinogenesis, 2013, 34(9):2071-2079.
[25] Wang J, Yan Y, Song D, et al.Reduced plasma mir-146a is a predictor of poor coronary collateral circulation in patients with coronary artery disease[J].Biomed Res Int, 2016, 2016(7):4285942.
[26] Oerlemans MI, Mosterd A, Dekker MS, et al.Early assessment of acute coronary syndromes in the emergency department: the potential diagnostic value of circulating microRNAs[J].EMBO Mol Med, 2012, 4(11):1176-1185.
[27] Wang X, Ha T, Liu L, et al.Increased expression of microRNA-146a decreases myocardial ischaemia/reperfusion injury[J].Cardiovasc Res, 2013, 97(3):432-442.
[28] Brudecki L, Ferguson DA, McCall CE, et al.MicroRNA-146a and RBM4 form a negative feed-forward loop that disrupts cytokine mRNA translation following TLR4 responses in human THP-1 monocytes[J].Immunol Cell Biol, 2013, 91(8):532-540.
[29] Taganov KD, Boldin MP, Chang K-J, et al.NF-kB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses[J].PNAS, 2006, 103(33):12481-12486.
[30] Huang W, Tian SS, Hang PZ, et al.Combination of microRNA-21 and microRNA-146a attenuates cardiac dys-function and apoptosis during acute myocardial infarction in mice[J].Mol Ther Nucleic Acids, 2016, 5(3):e296.
[31] Suzuki Y, Kim HW, Ashraf M, et al.Diazoxide potentiates mesenchymal stem cell survival via NF-kappaB-dependent miR-146a expression by targeting Fas[J].Am J Physiol Heart Circ Physiol, 2010, 299(4):H1077-H1082.
[32] Takahashi Y, Satoh M, Minami Y, et al.Expression of miR-146a/b is associated with the Toll-like receptor 4 signal in coronary artery disease: effect of rennin-angiotensin system blockade and statins on miRNA-146a/b and Toll-like receptor 4 levels[J].Clin Sci (Lond), 2010, 119(9):395-405.
[33] Hsieh JY, Huang TS, Cheng SM, et al.miR-146a-5p circuitry uncouples cell proliferation and migration, but not differen-tiation, in human mesenchymal stem cells[J].Nucleic Acids Res, 2013, 41(21):9753-9763.
[34] Perry MM, Moschos SA, Williams AE, et al.Rapid changes in microRNA-146a expression negatively regulate the IL-1beta-induced inflammatory response in human lung alveolar epithelial cells[J].J Immunol, 2008, 180(8):5689-5698.
